We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure (NORFLOCIR)

This study has been terminated.
(lack of recruitement)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01037959
First Posted: December 23, 2009
Last Update Posted: December 9, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2015
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)